Medication Review Program

Seattle Children's Hospital provides pediatric mental health second-opinion medication reviews. The program is funded by the states of Alaska, Washington and Wyoming.

Second-opinion reviews are requested from the state when psychiatric medication is prescribed outside of guidelines set by each state. Seattle Children’s role is to schedule second-opinion reviews between our psychiatrists and the pediatric prescribers within each state. In addition, we are responsible for sending the second-opinion review back to each state. This information is then completed and distributed by the state as necessary.

State-Specific Medicaid Guidelines

Alaska

  • Children receiving two or more atypical antipsychotics (AAPs)
  • Children age 5 or younger receiving psychotropic medications
  • Children receiving four or more psychotropic medications

Washington Second Opinion Network (SON)

  • Children receiving two or more atypical antipsychotics (AAPs)
  • Children age 5 or younger receiving psychotropic medications
  • Children receiving five or more psychotropic medications
  • High doses (ADHD, AAPs, antipsychotics)

Wyoming

  • Children receiving two or more atypical antipsychotics (AAPs)
  • Children age 4 or younger receiving psychotropic medications
  • Children receiving five or more psychotropic medications
  • High doses (two times FDA max)

It is important to note that Seattle Children’s Hospital psychiatrists are one step in the state-mandated medication review process. We do not set state guidelines or flag specific medications, but we do believe in the value of peer review and provider-to-provider collaboration.

Please contact us if you have questions at 206-987-2702 or by email.